You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Generic Companies with Tentative Approvals for: zoledronic acid


✉ Email this page to a colleague

« Back to Dashboard


zoledronic acid Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Dr Reddys Labs Ltd zoledronic acid 091187 4MMG INJECTABLE; INJECTION
Pharmaforce zoledronic acid 090330 EQ 4MG BASE/5ML INJECTABLE; IV (INFUSION)
Hospira Inc zoledronic acid 090709 EQ 4MG BASE/5ML INJECTABLE; IV (INFUSION)
Apotex Inc zoledronic acid 078533 EQ 4MG BASE/5ML INJECTABLE; IV (INFUSION)
Pfizer Inc zoledronic acid 203344 4MG/5ML INJECTABLE;INJECTION
Sun Pharma Global zoledronic acid 204051 4MG/100ML INJECTABLE;INJECTION
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.